US Federal Trade Commission Challenges Surmodics-Biocoat Merger Over Antitrust Concerns

A planned merger between medical device coating manufacturers Surmodics and Biocoat is facing an antitrust lawsuit from the US Federal Trade Commission. The FTC believes the move would create an illegal monopoly.